Company name
HAS Group
Company profile
HAS Healthcare Advanced Synthesis is part of the HAS Group, an integrated CDMO platform established in 2025 through the acquisition of Cerbios Pharma SA. Built on decades of Swiss precision and over forty years of combined experience, the Group delivers end‑to‑end chemical and biological solutions, including APIs, HPAPIs and ADCs, leveraging GMP‑certified sites across Switzerland to support partners from early development to commercial supply.
Date, time and room information
Tuesday, May 5, 14:45 - 15:00, room Sydney
Category
Commercial stage company
Speaker information
| Name | Position | Institution |
|---|---|---|
| Vitor Sousa | Director, Business Development |
